|
|
Home > Healthcare > Pharmaceutical > Drug Products
Pharmaceutical Pricing and Reimbursement in India
|
| Published Date:
September 2009
Published By:
Decision Resources
Page Count:
38
Order Code:
R55-676
|
|
|
|
Introduction
Faced with a dramatic slowdown in sales in mature pharmaceutical markets, multinational pharmaceutical companies
are looking to substantially increase their sales in India and other emerging markets. The Indian market
is growing by more than 10% per year, but foreign companies will need to overcome signifi cant obstacles to
succeed in a market currently dominated by domestic manufacturers.
Questions Answered in This Report
- The Indian population is forecast to grow from its present size of 1.2 billion to 1.7 billion in 2050. How will
the age breakdown of the population evolve over time? How will the balance between India’s urban and
rural populations change in the coming years?
- Only a minority of Indians have health insurance. What are the main forms of health insurance? How do
most Indians fund healthcare and medications?
- The Indian government controls the prices of 74 scheduled medicines. Which agents are subject to price
control? How are prices of other drugs regulated? How does the government penalize overcharging
for drugs? How do prices in India compare with prices in other markets? What pricing reforms is the
Indian government contemplating?
Scope
- Demographic trends: population breakdown by age and sex; population breakdown by geographic distribution.
- Organization and funding of healthcare: overview of the Indian healthcare system; access to healthcare; health insurance; out-of-pocket expenditures.
- Pharmaceutical pricing: historical price controls; current price control system; price adjustments;
penalties for overcharging for drugs; international price comparison; multinational companies’ pricing strategies.
- Outlook and implications for the pharmaceutical industry: encouraging commercial outlook;potential government reforms; opportunities and threats for multinationals.
|
Similar Products
• Mapping the Healthcare Landscape Bringing pharmaceuticals into focus
Published Nov 2009 by Datamonitor
• Snapshots US Pharmaceuticals 2009
Published Nov 2009 by Snapdata International Group
• Pharmaceuticals Industry Report
Published Nov 2009 by Plimsoll Publishing Ltd.
• Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis
Published Nov 2009 by Aruvian's R'search
• Pharmaceutical Industry in Mexico
Published Nov 2009 by Aruvian's R'search
• Antipsychotics Market Forecast
Published Oct 2009 by Datamonitor
• Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel classes
Published Oct 2009 by Datamonitor
• Prescription Drug Wholesaling in the US - Industry Risk Rating Report
Published Oct 2009 by IBISWorld
• Antidepressants Market Forecast
Published Oct 2009 by Datamonitor
|
|
|
|
0 items
